首页> 外文期刊>Journal of applied microbiology >Development and application of an in vitro methodology to determine thetransit tolerance of potentially probiotic Lactobacillus andBifidobacterium species in the upper human gastrointestinal tract
【24h】

Development and application of an in vitro methodology to determine thetransit tolerance of potentially probiotic Lactobacillus andBifidobacterium species in the upper human gastrointestinal tract

机译:开发和应用体外方法确定上消化道中潜在益生菌乳杆菌和双歧杆菌种类的转运耐受性

获取原文
获取原文并翻译 | 示例
       

摘要

An in vitro methodology which mimics in vivo human upper gastrointestinal transit was developed, The transit tolerance of potentially probiotic Lactobacillus and Bifidobacterium species was determined by exposing washed cell suspensions at 37 degrees C to a simulated gastric juice (pH 2.0), containing pepsin (0.3% w/v) and sodium chloride (0.5% w/v), and a simulated small intestinal juice (pH 8.0), containing pancreatin USP (1 g l(-1)) and sodium chloride (5 g l(-1)), and monitoring changes in total viable count periodically. The methodology was also employed to determine the effect of adding milk proteins (1 g l(-1)), hog gastric mucin (1 g l(-1)) and soyabean trypsin-chymotrypsin inhibitor [SBTCI] (1 g l(-1)) on transit tolerance. The majority (14 of 15) of isolates lost > 90% viability during simulated gastric transit. Only one isolate, Lactobacillus fermentum KLD, was considered intrinsically resistant. The addition of milk, proteins, singly and in combination, generally improved gastric transit tolerance. In this regard, two isolates, Lact. casei 212.3 and Bifidobacterium infantis 25962, exhibited 100% gastric transit tolerance in the presence of milk proteins. In general, the addition of hog gastric mucin did not influence simulated gastric transit tolerance of lactobacilli but tended to increase that of bifidobacteria. However, it increased that of Lact. casei 242 and Lact. salivarius 43338 but diminished that of B. bifidum 2715 and B. animalis Bo. Selected bile salts-resistant isolates were intrinsically tolerant to simulated small intestinal transit. Only Lact. casei F19 and B. adolescentis 15703T showed significant reduction in viability after 240 min. In general, the addition of milk proteins and SBTCI did not affect simulated small intestinal transit tolerance. However, they significantly improved the intrinsic resistance of Lact. casei F19 but diminished that of B. breve 15700T. It is concluded that, whereas the majority of bile salts-resistant lactobacilli and bifidobacteria may be intrinsically sensitive to gastric transit, they are intrinsically resistant to small intestinal transit. In addition, it is postulated that milk proteins and mucin may function as both buffering agents and inhibitors of digestive protease activity in vivo, thereby protecting ingested bacterial strains during upper gastrointestinal transit.
机译:开发了一种模仿体内人类上消化道运输的体外方法。通过将洗涤后的细胞悬浮液在37摄氏度下暴露于含有胃蛋白酶(0.3 %w / v)和氯化钠(0.5%w / v),以及含有胰酶USP(1 gl(-1))和氯化钠(5 gl(-1))的模拟小肠汁(pH 8.0),并定期监测总生存量的变化。该方法还用于确定添加牛奶蛋白(1 gl(-1)),猪胃粘蛋白(1 gl(-1))和大豆胰蛋白酶-胰凝乳蛋白酶抑制剂[SBTCI](1 gl(-1))的效果关于运输耐受性。在模拟的胃运输过程中,大多数分离株(15个中的14个)丧失了90%以上的生存能力。仅一种分离物,发酵乳杆菌KLD被认为具有内在抗性。单独或混合添加牛奶,蛋白质通常可以改善胃运输耐受性。在这方面,有两个分离株,Lact。酪蛋白212.3和婴儿双歧杆菌25962在牛奶蛋白存在下表现出100%的胃转运耐受性。通常,添加猪胃粘蛋白不会影响乳酸杆菌的模拟胃转运耐受性,但会增加双歧杆菌的耐受性。但是,它增加了乳酸。干酪242和Lact。唾液43338,但减少了双歧双歧杆菌2715和动物双歧杆菌Bo。所选的耐胆汁盐分离株本质上耐受模拟的小肠运输。只有乳汁。酪蛋白F19和青春芽孢杆菌15703T在240分钟后显示出活力的显着降低。通常,添加牛奶蛋白和SBTCI不会影响模拟的小肠运输耐受性。但是,它们显着提高了乳酸的内在抗性。 casei F19,但降低了B. breve 15700T。结论是,尽管大多数抗胆盐的乳杆菌和双歧杆菌可能对胃运输具有内在敏感性,但它们对小肠运输具有内在抗性。此外,假定牛奶蛋白和粘蛋白在体内可作为缓冲剂和消化蛋白酶活性的抑制剂,从而在上消化道运输过程中保护摄入的细菌菌株。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号